Showing posts with label Lasofoxifene. Show all posts
Showing posts with label Lasofoxifene. Show all posts
Friday, March 05, 2010
Lasofoxifene in postmenopausal women with osteoporsis
CONCLUSIONS: In postmenopausal women with osteoporosis, lasofoxifene at a dose of 0.5 mg per day was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. (ClinicalTrials.gov number, NCT00141323.) 2010 Massachusetts Medical Society"
Subscribe to:
Posts
(
Atom
)
